Latest News in the pharma Industry

Research & Development

Significant Research from the Forsyth Institute Explains Why Popular Antacids May Increase Chance of Bone Fractures

Significant Research from the Forsyth Institute Explains Why Popular Antacids May Increase Chance of Bone Fractures

27 Mar 2015

Read more 
Shire and Cincinnati Children’s Establish Rare Disease Research Collaboration

Shire and Cincinnati Children’s Establish Rare Disease Research Collaboration

27 Mar 2015

Read more 
Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China and Around the World

Lilly and Innovent Biologics Announce a Strategic Alliance to Bring Potential Oncology Therapies to Patients in China and Around the World

26 Mar 2015

Read more 
Taconic Biosciences and Cellaria Biosciences Agree to Scientific Collaboration to Facilitate Xenograft Use in Oncology Research

Taconic Biosciences and Cellaria Biosciences Agree to Scientific Collaboration to Facilitate Xenograft Use in Oncology Research

26 Mar 2015

Read more 
Horizon Discovery Group and Partners Awarded up to £6.2M Funding Under Advanced Manufacturing Supply Chain Initiative

Horizon Discovery Group and Partners Awarded up to £6.2M Funding Under Advanced Manufacturing Supply Chain Initiative

25 Mar 2015

Read more 
Vaccine Against Placental Malaria Ready to Start Human Tests

Vaccine Against Placental Malaria Ready to Start Human Tests

24 Mar 2015

Read more 
Boehringer Ingelheim's Investigational Biologic Cleared Skin Better than Ustekinumab in Head-to-Head Phase II Psoriasis Study

Boehringer Ingelheim's Investigational Biologic Cleared Skin Better than Ustekinumab in Head-to-Head Phase II Psoriasis Study

24 Mar 2015

Read more 
UK CROs to Unveil Collaboration at Nordic Event

UK CROs to Unveil Collaboration at Nordic Event

23 Mar 2015

Read more 
Lilly and Hanmi Announce Exclusive Agreement for the Development and Commercialization of an Immunological Therapy

Lilly and Hanmi Announce Exclusive Agreement for the Development and Commercialization of an Immunological Therapy

20 Mar 2015

Read more 
AstraZeneca Announces Positive Phase III Top-Line Results for PT003 from PINNACLE 1 and PINNACLE 2 Studies in COPD

AstraZeneca Announces Positive Phase III Top-Line Results for PT003 from PINNACLE 1 and PINNACLE 2 Studies in COPD

20 Mar 2015

Read more 
Selvita Expands its Proteomics Services Offer

Selvita Expands its Proteomics Services Offer

19 Mar 2015

Read more 
New Data Investigating Merck's Keytruda in Advanced Non-Small Cell Lung Cancer and Mesothelioma to be Presented at AACR 2015

New Data Investigating Merck's Keytruda in Advanced Non-Small Cell Lung Cancer and Mesothelioma to be Presented at AACR 2015

19 Mar 2015

Read more